{"id":"https://openalex.org/W1997995563","doi":"https://doi.org/10.1016/j.amjopharm.2007.10.002","title":"Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice","display_name":"Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice","publication_year":2007,"publication_date":"2007-09-01","ids":{"openalex":"https://openalex.org/W1997995563","doi":"https://doi.org/10.1016/j.amjopharm.2007.10.002","mag":"1997995563","pmid":"https://pubmed.ncbi.nlm.nih.gov/17996658"},"language":"en","primary_location":{"id":"doi:10.1016/j.amjopharm.2007.10.002","doi":"https://doi.org/10.1016/j.amjopharm.2007.10.002","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.amjopharm.2007.10.002","pdf_url":null,"source":{"id":"https://openalex.org/S144209978","display_name":"The American Journal of Geriatric Pharmacotherapy","issn_l":"1543-5946","issn":["1543-5946","1876-7761"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The American Journal of Geriatric Pharmacotherapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5078029213","display_name":"Carolyn Harley","orcid":"https://orcid.org/0000-0002-4003-8316","observed_orcids":["https://orcid.org/0000-0002-4003-8316"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Carolyn R. Harley","raw_affiliation_strings":["Health Economics and Outcomes, i3 Innovus, Palo Alto, California 94303, USA. carolyn.harley@i3innovus.com","Health Economics and Outcomes, i3 Innovus, Palo Alto, California 94303, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Health Economics and Outcomes, i3 Innovus, Palo Alto, California 94303, USA. carolyn.harley@i3innovus.com","institution_ids":[]},{"raw_affiliation_string":"Health Economics and Outcomes, i3 Innovus, Palo Alto, California 94303, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5106733906","display_name":"Sanjay K Gandhi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sanjay Gandhi","raw_affiliation_strings":["AstraZeneca Pharmaceuticals, L.P., Wilmington, Delaware"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca Pharmaceuticals, L.P., Wilmington, Delaware","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032555535","display_name":"James W. Blasetto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James Blasetto","raw_affiliation_strings":["AstraZeneca Pharmaceuticals, L.P., Wilmington, Delaware"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca Pharmaceuticals, L.P., Wilmington, Delaware","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059547603","display_name":"Herbert C. Heien","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Herbert Heien","raw_affiliation_strings":["Health Economics and Outcomes, i3 Innovus, Eden Prairie, Minnesota"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Health Economics and Outcomes, i3 Innovus, Eden Prairie, Minnesota","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050998332","display_name":"Rahul Sasan\u00e9","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rahul Sasane","raw_affiliation_strings":["AstraZeneca Pharmaceuticals, L.P., Wilmington, Delaware"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca Pharmaceuticals, L.P., Wilmington, Delaware","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5071901774","display_name":"Stephanie Nelson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephanie P. Nelson","raw_affiliation_strings":["Health Economics and Outcomes, i3 Innovus, Eden Prairie, Minnesota"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Health Economics and Outcomes, i3 Innovus, Eden Prairie, Minnesota","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5078029213"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.6695,"has_fulltext":false,"cited_by_count":28,"citation_normalized_percentile":{"value":0.74908003,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"5","issue":"3","first_page":"185","last_page":"194"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12465","display_name":"Cancer, Lipids, and Metabolism","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rosuvastatin","display_name":"rosuvastatin","score":0.9559999704360962},{"id":"https://openalex.org/keywords/statins","display_name":"statins","score":0.8870000243186951},{"id":"https://openalex.org/keywords/ldl-cholesterol","display_name":"LDL cholesterol","score":0.8119999766349792},{"id":"https://openalex.org/keywords/ldl-c-target-attainment","display_name":"LDL-C goal attainment","score":0.9380000233650208},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.9430000185966492},{"id":"https://openalex.org/keywords/ncep-atp-iii-guidelines","display_name":"NCEP ATP III guidelines","score":0.8069999814033508},{"id":"https://openalex.org/keywords/atorvastatin","display_name":"atorvastatin","score":0.8080000281333923},{"id":"https://openalex.org/keywords/fluvastatin","display_name":"fluvastatin","score":0.9300000071525574},{"id":"https://openalex.org/keywords/lovastatin","display_name":"lovastatin","score":0.9700000286102295},{"id":"https://openalex.org/keywords/pravastatin","display_name":"pravastatin","score":0.9879999756813049},{"id":"https://openalex.org/keywords/simvastatin","display_name":"simvastatin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/lipid-lowering-therapy","display_name":"lipid-lowering therapy","score":0.7099999785423279},{"id":"https://openalex.org/keywords/cardiovascular-risk","display_name":"cardiovascular risk","score":0.6169999837875366},{"id":"https://openalex.org/keywords/statin-comparison","display_name":"statin comparison","score":0.382999986410141},{"id":"https://openalex.org/keywords/medicare-advantage","display_name":"Medicare Advantage","score":0.47999998927116394},{"id":"https://openalex.org/keywords/managed-care-claims-data","display_name":"managed care claims data","score":0.7689999938011169},{"id":"https://openalex.org/keywords/dyslipidemia","display_name":"dyslipidemia","score":0.6100000143051147}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8757006525993347},{"id":"https://openalex.org/C2780499067","wikidata":"https://www.wikidata.org/wiki/Q415159","display_name":"Rosuvastatin","level":2,"score":0.7227917313575745},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.655659019947052},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5815825462341309},{"id":"https://openalex.org/C2778402494","wikidata":"https://www.wikidata.org/wiki/Q599756","display_name":"National Cholesterol Education Program","level":4,"score":0.5748029351234436},{"id":"https://openalex.org/C2776839432","wikidata":"https://www.wikidata.org/wiki/Q954845","display_name":"Statin","level":2,"score":0.5173256397247314},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.451084703207016},{"id":"https://openalex.org/C104863432","wikidata":"https://www.wikidata.org/wiki/Q614304","display_name":"Pharmacy","level":2,"score":0.44950544834136963},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.4465812146663666},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.43353384733200073},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.3898622691631317},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.10003775358200073},{"id":"https://openalex.org/C2780578515","wikidata":"https://www.wikidata.org/wiki/Q657193","display_name":"Metabolic syndrome","level":3,"score":0.09112203121185303},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.07819870114326477},{"id":"https://openalex.org/C511355011","wikidata":"https://www.wikidata.org/wiki/Q12174","display_name":"Obesity","level":2,"score":0.07680654525756836}],"mesh":[{"descriptor_ui":"D000068718","descriptor_name":"Rosuvastatin Calcium","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000069059","descriptor_name":"Atorvastatin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077340","descriptor_name":"Fluvastatin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000924","descriptor_name":"Anticholesteremic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003327","descriptor_name":"Coronary Disease","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D005229","descriptor_name":"Fatty Acids, Monounsaturated","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005464","descriptor_name":"Fluorobenzenes","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006538","descriptor_name":"Heptanoic Acids","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006937","descriptor_name":"Hypercholesterolemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008078","descriptor_name":"Cholesterol, LDL","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D008148","descriptor_name":"Lovastatin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008329","descriptor_name":"Managed Care Programs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011758","descriptor_name":"Pyrroles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016017","descriptor_name":"Odds Ratio","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016208","descriptor_name":"Databases, Factual","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017035","descriptor_name":"Pravastatin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019821","descriptor_name":"Simvastatin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.amjopharm.2007.10.002","doi":"https://doi.org/10.1016/j.amjopharm.2007.10.002","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.amjopharm.2007.10.002","pdf_url":null,"source":{"id":"https://openalex.org/S144209978","display_name":"The American Journal of Geriatric Pharmacotherapy","issn_l":"1543-5946","issn":["1543-5946","1876-7761"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The American Journal of Geriatric Pharmacotherapy","raw_type":"journal-article"},{"id":"pmid:17996658","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17996658","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The American journal of geriatric pharmacotherapy","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":30,"referenced_works":["https://openalex.org/W424467158","https://openalex.org/W1967789083","https://openalex.org/W1968240228","https://openalex.org/W2024276638","https://openalex.org/W2035081010","https://openalex.org/W2057721505","https://openalex.org/W2058647728","https://openalex.org/W2066325758","https://openalex.org/W2100270330","https://openalex.org/W2106343349","https://openalex.org/W2115316104","https://openalex.org/W2127232229","https://openalex.org/W2135171522","https://openalex.org/W2135631433","https://openalex.org/W2135648839","https://openalex.org/W2144002840","https://openalex.org/W2146228563","https://openalex.org/W2152789823","https://openalex.org/W2154704322","https://openalex.org/W2160810969","https://openalex.org/W2166302161","https://openalex.org/W2166894879","https://openalex.org/W2322095705","https://openalex.org/W2342247435","https://openalex.org/W2477872031","https://openalex.org/W2491061016","https://openalex.org/W4230870013","https://openalex.org/W4242237340","https://openalex.org/W4246764494","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2160810969","https://openalex.org/W2019549804","https://openalex.org/W1539315778","https://openalex.org/W1992029268","https://openalex.org/W2122444136","https://openalex.org/W1996661696","https://openalex.org/W2013694999","https://openalex.org/W1973523240","https://openalex.org/W62522581","https://openalex.org/W2152954903"],"abstract_inverted_index":null,"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}